Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Transgender men and women, nonbinary people and cisgender men also get breast cancer—but are not reflected in breast cancer campaigns.
Targeted therapy tucatinib improves survival in people with HER2-positive breast cancer that has spread to the brain.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.